Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF OTHER ACCRUED EXPENSES (Details)

v3.21.2
SCHEDULE OF OTHER ACCRUED EXPENSES (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Payables and Accruals [Abstract]    
Accrued royalties $ 3,572 $ 2,710
Upfront Medicare payment 2,066
Operating lease liabilities 1,030 1,027
All others 1,056 1,182
Accrued professional fees 931 854
Unclaimed property 565 565
Contingent consideration 473 398
Accrued pharma services invoices 438 108
Taxes payable 248 334
Accrued lab costs - diagnostics 514 161
Financing lease liabilities 98 177
ESPP payable 37 108
Accrued sales and marketing - diagnostics 41 51
Deferred revenue 40 54
Total other accrued expenses $ 9,043 $ 9,795